Bevacizumab/Carboplatin/Paclitaxel Regimen

Preferred Label : Bevacizumab/Carboplatin/Paclitaxel Regimen;

NCIt synonyms : Carbo-Taxol-Avastin Regimen; Carboplatin-Paclitaxel-Bevacizumab; Carboplatin/Paclitaxel/Bevacizumab; Carboplatin-Taxol-Bevacizumab; Carboplatin-Taxol-Bevacizumab Regimen;

NCIt related terms : carboplatin-paclitaxel-bevacizumab regimen; Carboplatin and Paclitaxel (CP) and Bevacizumab;

NCIt definition : A regimen consisting of bevacizumab, carboplatin and paclitaxel that can be used in the treatment of endometrial, ovarian, fallopian tube and primary peritoneal, vulvar and cervical cancers and non-small cell lung cancer (NSCLC).;

Alternative definition : NCI-GLOSS: A chemotherapy combination used to treat advanced, nonsquamous non-small cell lung cancer. It includes the drugs carboplatin, paclitaxel (Taxol), and bevacizumab.;

NCIt note : Source: NCCN Guidelines 2007;

Codes from synonyms : CDR0000663013; CDR0000663014; 29570;

Details

Origin ID

C63413;

UMLS CUI

C1880001;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Carboplatin [NCIt concept]
- Paclitaxel [NCIt concept]
concept_is_in_subset
- GDC Regimen Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Lung Non-Small Cell Carcinoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients